Tweet Archive for hashtag “#Merz” « page 6

IBoNT-A in Clinical Literature aes.sagepub.com/content/33/1_s… #Xeomin #Bocouture #Merz

5:43pm Jun 20 2013 —

IBoNT-A Background, MoA & Manufacturing aes.sagepub.com/content/33/1_s… #Xeomin #Bocouture #Merz

5:41pm Jun 20 2013 —

Special Issue: Expanding Treatment Options for Neuromodulators: An Introduction to IBoNT-A aes.sagepub.com/content/33/1_s… #Merz #Xeomin #Bocouture

5:34pm Jun 20 2013 —

Expanding Treatment Options for Neuromodulators: An Introduction to
IBoNT-A youtube.com/watch?v=rxdHWJ… #Xeomin #Xeomeen #Bocouture #Merz

5:31pm Jun 20 2013 —

Botulinum Toxins for Facial Lines: A Concise Review link.springer.com/article/10.100… #springerlink #Allergan #Galderma #Valeant #Merz #Ipsen

10:03am Jun 13 2013 —

Allergan’s Dominance in Facial Injectables Challenged by Acquisitions Among Competitors prnewswire.com/news-releases/… #Merz #Valeant #Galderma #JnJ

6:29am Jun 10 2013 —

12:40pm Jun 4 2013 —

Convergence of Medicine & Neurotoxins: BoNTA applications in Aesthetic Medicine Global Evidence-Based Consensus onlinelibrary.wiley.com/doi/10.1111/ds… #Merz

3:24am Apr 5 2013 —

Multicenter, Randomized, Phase III Study of a Single Dose of IBoNTA in the Treatment of GLs
onlinelibrary.wiley.com/doi/10.1111/ds…
#Xeomin #Bocouture #Merz

3:21am Apr 5 2013 —

RT @FrentzenJeffrey: Obagi, Valeant Raise Price As Bidding War Breaks Out ow.ly/jIWmi #Merz #Valeant #cosmetics #dermatology

in reply to FrentzenJeffrey — 8:19am Apr 4 2013 —